TULSI PATEL: Open Payments
NPI 1235758566 · GARDEN CITY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 10 payments from 7 companies in 2025. Trend: 2023 $1,041 · 2024 $263 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $78 |
| Endo USA, Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Astellas Pharma US Inc | 1 | $25 |
| 180 Medical, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| ACCORD HEALTHCARE, INC. | 1 | $23 |
Products named: GEMTESA, XIAFLEX, KEYTRUDA, Xtandi, GENTLECATH, Nubeqa, Camcevi, ORGOVYX.
Industry payments across GA — which companies pay providers there.
